The debt of ADMA BIOLOGICS, INC. over the past 10 years
Chart ADMA BIOLOGICS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, ADMA BIOLOGICS, INC. had liquid cash of $87.63M and total debt of $72.14M: net cash of $15.49M. It had more liquid cash than debt at 3 of the 6 year-ends shown. Total debt was highest at the end of fiscal 2019 ($83.2M) and lowest at the end of fiscal 2016 ($20.22M). No net cash figure is on file for fiscal 2020, 2021, 2022 and 2023.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $87.63M | $72.14M | $15.49M |
| 2024ended Dec 31, 2024 | $103.15M | $72.34M | $30.81M |
| 2023ended Dec 31, 2023 | $51.35M | — | — |
| 2022ended Dec 31, 2022 | $86.52M | — | — |
| 2021ended Dec 31, 2021 | $51.09M | — | — |
| 2020ended Dec 31, 2020 | $55.92M | — | — |
| 2019ended Dec 31, 2019 | $26.75M | $83.2M | -$56.45M |
| 2018ended Dec 31, 2018 | $22.75M | $44.08M | -$21.32M |
| 2017ended Dec 31, 2017 | $43.11M | $42.97M | $136.72K |
| 2016ended Dec 31, 2016 | $15.31M* | $20.22M | -$4.92M |
Fiscal years as ADMA BIOLOGICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ADMA BIOLOGICS, INC.
- The revenue of ADMA BIOLOGICS, INC.
- The profitability of ADMA BIOLOGICS, INC.
- The cash flow of ADMA BIOLOGICS, INC.
- All of ADMA BIOLOGICS, INC.'s financials, charted
Companies of a similar size
Not investment advice. This page shows what ADMA BIOLOGICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.